Addex Therapeutics
ADXN
5 hedge funds and large institutions have $4.71K invested in Addex Therapeutics in 2025 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
154% more capital invested
Capital invested by funds: $1.85K → $4.71K (+$2.85K)
25% more funds holding
Funds holding: 4 → 5 (+1)
0.02% more ownership
Funds ownership: 0.01% → 0.03% (+0.02%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$2.57K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.33K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GI
GAMMA Investing
Foster City,
California
|
-$343 |
| 2 |
SS
SBI Securities
Tokyo,
Japan
|
-$34 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $2.32K | +$2.57K | +300 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $1.2K | +$1.33K | +155 | +15,500% |
|
|
GI
3
GAMMA Investing
Foster City,
California
| $625 | -$343 | -40 | -33% |
|
4
RhumbLine Advisers
Boston,
Massachusetts
| $554 | – | – | – |
|
|
SS
5
SBI Securities
Tokyo,
Japan
| $8 | -$34 | -4 | -80% |
|
ADXN Hedge Fund Activity: Q4 2025 in Review
5 of the 8,232 institutional investors tracked by Wall St. Rank reported a position in Addex Therapeutics (ADXN) for Q4 2025, worth a combined $4.71K — up 154% from $1.85K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ADXN positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Morgan Stanley, opening a new position worth an estimated $2.57K. The largest seller was GAMMA Investing, cutting an estimated $343.
- 5 institutional investors held Addex Therapeutics (ADXN) as of Q4 2025, up from 4 in Q3 2025.
- Funds reported $4.71K of Addex Therapeutics stock for Q4 2025, up 154% quarter-over-quarter.
- 1 fund opened new Addex Therapeutics positions in Q4 2025 and 0 closed out, a net change of +1 holder.
- The largest Addex Therapeutics buyer in Q4 2025 was Morgan Stanley, an estimated $2.57K added.
- The largest Addex Therapeutics seller in Q4 2025 was GAMMA Investing, an estimated $343 sold.
Based on aggregated 13F filings for Q4 2025.